Tag: Novo Nordisk

Lancet Study: Semaglutide Reduces Risk of CV Death and Worsening Heart Failure

PLAINSBORO, N.J- Recently, The Lancet published a new pooled, participant-level analysis of patients…

ME Desk

Dose Check: Your Personalized Insulin Coach

More than 95% of diabetics suffer from type 2 diabetes, which was…

Harshad Hussain B

Is Awiqliยฎ approved for diabetes?

Denmark-21 March 2024- Novo Nordisk announced that the European Medicines Agencyโ€™s Committee…

ME Desk